Sigachi Industries held its first extraordinary general meeting for FY27 on September 15, 2026, seeking shareholder approval for a preferential issue of convertible warrants and an increase in authorized share capital.

The meeting, conducted via video conference under SEBI Listing Obligations and Disclosure Requirements Regulations, commenced at 11:00 am and concluded at 11:28 am. A total of 58 members attended, satisfying the quorum requirement.

Key Resolutions

The Board of Directors placed two special business items before the shareholders:

• Increase in the authorized share capital and consequent alteration of the capital clause in the Memorandum of Association.
• Issue of up to 11,00,00,000 convertible warrants to promoters and non-promoters on a preferential basis.

Meeting Proceedings

Mr. Amit Raj Sinha, Managing Director and CEO, chaired the meeting. The Company Secretary, Mr. Vivek Kumar, welcomed attendees and outlined the e-voting procedure. M/s. Aakanksha Dubey & Co., Practicing Company Secretary, was appointed as the Scrutinizer to oversee the remote e-voting and e-voting at the EGM process.

Since all resolutions had already been put to vote through remote e-voting, no proposing or seconding of resolutions occurred during the physical session. Members who had not cast their votes electronically were given the opportunity to do so during the meeting. Queries raised by members regarding the preferential issue were addressed by the management.

Attendance

The following directors and key managerial personnel were present:

Other invitees included Ms. Aakanksha Sachin Dubey (Secretarial Auditor and Scrutinizer) and Mr. Lijo Stephen Chacko (Deputy Group CEO).

The voting results, including the Scrutinizer's Report, will be disseminated to the exchanges and posted on the company's website in due course.

Sigachi Industries Limited has scheduled its Extra-Ordinary General Meeting (EGM) for September 15, 2026, to seek shareholder approval for a ₹290.4 crore preferential allotment of convertible warrants and an increase in authorized share capital.

The Board of Directors approved the transaction during its meeting on August 22, 2026. The issuance involves up to 11 crore convertible warrants priced at ₹26.40 per warrant, targeting promoters and identified non-promoter investors. The company will also raise its authorized share capital from ₹43 crore to ₹60 crore to accommodate the equity shares resulting from warrant conversions.

Capital Raise Details

The preferential issue targets 43 investors, with the promoter group receiving the largest allocation. Mr. Amit Raj Sinha, Managing Director and CEO, will receive 7.5 crore warrants. The remaining 3.5 crore warrants are allocated to non-promoter entities, including Trikaya Wealth Advisors Private Limited and Rajendra Prasad Adiraju.

Post-allotment and assuming full conversion, promoter holding will stand at 43.73%, while public holding will be 56.27% of the post-issue paid-up capital. Care Ratings Limited has been appointed as the monitoring agency to oversee the use of proceeds.

Use of Proceeds

The company intends to utilize the net proceeds towards specific business objectives:

• Acquisition and expansion of Active Pharmaceutical Ingredients (API) and Excipients, including Croscarmellose Sodium (CCS): ₹190.40 crore
• Working Capital requirements: ₹60.00 crore
• General Corporate Purposes: ₹40.00 crore

The tentative timeline for utilization is three years for API expansion and two years for working capital and general corporate purposes. Unutilized funds will be deposited in term deposits with scheduled commercial banks or NBFCs.

Other Board Approvals

In addition to the capital raise, the board approved deviations in the object clause of the initial public offer prospectus, pending shareholder consent. The company also appointed M/s RSM Astute Consulting Private Limited as its internal auditor for FY27, replacing M/s PRSV & Co. LLP, which resigned due to professional pre-occupation. M/s Aakanksha Dubey & Co. was appointed as the scrutinizer for both the EGM and the forthcoming Annual General Meeting (AGM).

Trading Window Closure

Pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window remains closed for designated persons until 48 hours after the conclusion of the board meeting. The meeting was convened by Vivek Kumar, Company Secretary and Compliance Officer.